PF-05280586
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-05280586, covering 2017-06-08 to 2019-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) [Phase 2]